|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/4745 | |||
| A61K 31/7088 | |||
| A61K 38/17 | |||
| A61P 29/00 |
| (11) | Number of the document | 2849788 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13791248.1 |
| Date of filing the European patent application | 2013-05-17 | |
| (97) | Date of publication of the European application | 2015-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2013/000488 |
| Date | 2013-05-17 |
| (87) | Number | WO 2013/170367 |
| Date | 2013-11-21 |
| (30) | Number | Date | Country code |
| 201261648319 P | 2012-05-17 | US |
| (72) |
WALLEY, Keith, R., CA
BOYD, John, H, CA
RUSSELL, James, A., CA
|
| (73) |
Cyon Therapeutics Inc.,
2500-700 West Georgia Street, Vancouver, British Columbia V7Y 1K8,
CA
|
| (54) | PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) INHIBITORS FOR USE IN TREATING SEPSIS AND SEPTIC SHOCK |
| PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) INHIBITORS FOR USE IN TREATING SEPSIS AND SEPTIC SHOCK |